Welcome to our dedicated page for JANUS LIVING SEC filings (Ticker: JAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for JanOne Inc. under the historical ticker JAN provides access to regulatory documents that trace the company’s corporate evolution into ALT5 Sigma Corporation and its development as a fintech and healthcare-focused issuer. These filings, which include Forms 8-K and other reports, document material events such as acquisitions, capital raises, governance changes, and the formal confirmation of the corporate name and ticker symbol change from JanOne Inc. (JAN) to ALT5 Sigma Corporation (ALTS).
Investors can review filings that describe the acquisition of blockchain financial technology provider ALT5 Sigma Inc. and its subsidiaries, the company’s inclusion in the Russell Microcap Index, and subsequent transactions involving registered direct offerings, private placements, and the establishment of a cryptocurrency treasury strategy involving WLFI tokens. Other filings outline the purchase of the Mswipe business, which offers multi-currency, fiat- and crypto-enabled payment card services, and detail the related consideration, warrants, and promissory notes.
These documents also provide insight into the company’s governance and oversight, including board and committee changes, compensation arrangements for executives, and the formation of special committees to review specific matters. For those studying the company’s biotech activities, periodic reports and current reports can be used to follow disclosures about its efforts to develop non-addicting pain treatments and address the opioid crisis.
On Stock Titan, SEC filings for JAN serve primarily as a historical record, since the company has adopted the name ALT5 Sigma Corporation and trades under the ticker ALTS. Users can use this page to locate past 8-Ks and related filings associated with the JAN symbol, then follow the sequence of disclosures into the ALT5 Sigma era. AI-powered tools on the platform can help summarize lengthy filings, highlight key terms of transactions, and make complex capital structure and governance information easier to interpret.
Janus Living, Inc. chief operating officer Jeffrey H. Miller increased his direct stake through both a share purchase and an equity award. He bought 7,500 shares of Class A-1 Common Stock in an open-market-style transaction from the underwriters at $20.00 per share in connection with the company’s initial public offering. He also received a grant of 12,500 LTIP Units, which are fully vested profits-interest units in Janus Living OP, LLC that can be converted into OP Units and ultimately into Class A-1 Common Stock on a one-for-one basis, with no expiration date.
Janus Living, Inc. closed its underwritten public offering of 48,300,000 shares of Class A-1 common stock, including full exercise of the underwriters’ option, and put in place the core agreements that will govern its structure and financing.
The company entered into an underwriting agreement and an amended and restated operating agreement for Janus Living OP, LLC, where it holds a 71.1% interest and manages operations. The operating partnership can issue various unit classes, and most common unitholders gain redemption or exchange rights into Class A-1 shares after 14 months.
A new management agreement with Healthpeak Investment Management, LLC appoints an external manager to run day-to-day operations for an initial three-year term, with a $10.0 million annual base fee plus a variable adjustment tied to changes in the gross book value of investments, subject to tiered reductions at higher asset levels. An exclusivity agreement splits business focus between senior housing for Janus and medical office and life science real estate for Healthpeak.
A stockholders agreement gives Healthpeak board nomination rights tied to its ownership, and a registration rights agreement covers 214,734,026 shares of Class A-1 common stock, including 75,917,780 shares issuable upon redemption of common units. Janus also secured new credit facilities consisting of a $500 million revolving credit facility maturing in 2030 and a $100 million delayed-draw term loan facility maturing in 2031, both SOFR-based with leverage- or rating-based pricing and customary covenants. The company adopted amended and restated charter documents and bylaws and elected a new board that includes Healthpeak designees.
Janus Living, Inc. files a prospectus for an initial public offering of 42,000,000 shares of Class A-1 common stock. The initial public offering price is $20.00 per share, implying aggregate gross proceeds of $840,000,000. All offered shares are primary shares being sold by the company. The underwriters may purchase an additional 6,300,000 shares within 30 days. Healthpeak (an indirect subsidiary of Healthpeak Properties, Inc.) will externally manage Janus Living and, after the offering and formation transactions, will retain majority voting control through Class A-2 shares. The company intends to elect REIT status beginning with the taxable year ending December 31, 2026 and will operate an initial portfolio of senior housing assets held and operated under RIDEA structures totaling 10,422 units as of December 31, 2025.
Janus Living, Inc. reported that Katherine M. Sandstrom filed an initial Form 3 as a director, which is a required statement of her beneficial ownership when she joins the board. The summary data in this filing shows no reported transactions and no listed holdings or derivative positions.
Janus Living, Inc. reported that Porter Tracy A, who serves as EVP & General Counsel, filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting officer of the company but does not show any buy or sell transactions.
Janus Living, Inc. filed an insider ownership report identifying Mabry Adam G as its Chief Investment Officer. This Form 3 excerpt shows no reported transactions, holdings, or derivative positions for the reporting person.
Janus Living, Inc. filed an insider ownership report identifying Shawn G. Johnston as an officer with the title EVP & Chief Accounting Officer. The filing lists no insider share purchases, sales, gifts, option exercises, or other equity transactions for this reporting person.
Janus Living, Inc. director Arabia John V filed an initial Form 3, which is an insider ownership report. This filing lists no equity or derivative transactions for the reporting person, serving only as an initial disclosure of status as a director of the company.
Alt5 Sigma Corporation filed a current report to share that it issued a press release on September 4, 2025 announcing an update to its $WLFI holdings. The company furnished this press release as Exhibit 99.1 under a Regulation FD disclosure item, meaning it is providing the same information to all investors at the same time. The information in this section and the exhibit is being furnished to the SEC rather than filed, so it is not subject to certain liability provisions and is not automatically included in other Securities Act or Exchange Act filings unless specifically incorporated by reference.